Glenmark Life Sciences files Draft Red Herring Prospectus for IPO with Sebi

Glenmark

Glenmark Pharmaceuticals wholly-owned arm Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP)  for an initial public offer with market regulator Sebi. The offer comprises a fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences Ltd, by Glenmark Pharmaceuticals Ltd. The board of directors of Glenmark Pharmaceuticals Ltd during its meeting on April 16 approved the offer for sale of up to 73,05,245 equity shares of Rs 2 apiece as part of the IPO.

  • Glenmark Pharmaceuticals wholly-owned arm Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP)  for an initial public offer with market regulator Sebi.

Leave a Reply

Your email address will not be published. Required fields are marked *